"Pro Medicus gets a new bull at Macquarie, where analysts see the healthcare imaging software provider increasing its share of the U.S. market to 25% by FY 2035. The analysts tell clients in a note that the market is assuming only a 20% market share by FY 2035. They reckon that the Australia-listed company's current contracted revenue implies a 7% market share in FY 2025. With customer feedback suggesting that Pro Medicus's Visage 7 software is faster and more efficient than that offered by rivals, they see that share hitting 15% by FY 2030 and continuing to rise. Macquarie initiates coverage of the stock with an outperform rating and A$120.00 target price. Shares are up 1.7% at A$108.57"
" Pro Medicus Started With A$120.00/Share Target Price by Macquarie"
"Pro Medicus gets a new bull at Macquarie, where analysts see...
Add PME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$113.52 |
Change
1.420(1.27%) |
Mkt cap ! $11.85B | |||
| Open | High | Low | Value | Volume |
| $112.10 | $113.93 | $112.06 | $16.17M | 142.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 144 | $113.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $113.67 | 328 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$113.59 |
Change
1.420 ( 1.11 %) |
||||
| Open | High | Low | Volume | ||
| $112.17 | $113.91 | $112.17 | 26535 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| PME (ASX) Chart |